NEW YORK (GenomeWeb News) – Roche today reported flat molecular diagnostics sales for the first nine months of 2013 compared to the first nine months of 2012.

The Swiss pharmaceuticals, diagnostics, and research products firm posted overall sales of CHF 34.87 billion ($38.63 billion) for the nine months ended Sept. 30, up 3 percent from CHF 33.69 for the first nine months of 2012.

Its diagnostics sales were up 2 percent to CHF 7.68 billion from CHF 7.50 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."